Factors impacting the efficacy of venlafaxine extended release 75–225 mg/day in patients with major depressive disorder: exploratory post hoc subgroup analyses of a randomized, double-blind, placebo-controlled study in Japan

References

• American Psychiatric AssociationPractice guideline for the treatment of patients with major depressive disorder 3 rd editionAmerican Psychiatric Association2010 Available from: http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdfAccessed March 12, 2018
   Google Scholar
• NuttDJDavidsonJRGelenbergAJInternational consensus statement on major depressive disorderJ Clin Psychiatry201071Suppl E1e08
   Google Scholar
• Japanese Society of Mood DisordersGuideline for treatment of major depressive disorder by the Japanese Society of Mood DisordersJapanese Society of Mood Disorders2013 Available from: http://www.secretariat.ne.jp/jsmd/mood_disorder/img/130924.pdfAccessed March 12, 2018 Japanese
   Google Scholar
• PapakostasGISerotonin norepinephrine reuptake inhibitors: spectrum of efficacy in major depressive disorderPrim Psychiatry2009165 Suppl 41624
   Google Scholar
• HiguchiTKamijimaKNakagomeKA randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in JapanInt Clin Psychopharmacol201631181926513202
   PubMed Web of Science ®Google Scholar
• HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
   PubMed Web of Science ®Google Scholar
• MontgomerySAAsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry1979134382389444788
   PubMed Web of Science ®Google Scholar
• BechPGramLFDeinEQuantitative rating of depressive statesActa Psychiatr Scand19755131611701136841
   PubMed Web of Science ®Google Scholar
• BechPAllerupPGramLFThe Hamilton depression scale. Evaluation of objectivity using logistic modelsActa Psychiatr Scand19816332902997015793
   PubMed Web of Science ®Google Scholar
• ClearyPGuyWFactor analysis of the Hamilton depression scaleDrugs under Experimental and Clinical Research19771115120
   Google Scholar
• RushAJTrivediMHIbrahimHMThe 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depressionBiol Psychiatry200354557358312946886
   PubMed Web of Science ®Google Scholar
• SheltonRCPrakashAMallinckrodtCHPatterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depressionInt J Clin Pract20076181337134817627710
   PubMed Web of Science ®Google Scholar
• NelsonJCDelucchiKLSchneiderLSModerators of outcome in late-life depression: a patient-level meta-analysisAm J Psychiatry2013170665165923598969
   PubMed Web of Science ®Google Scholar
• ElkinISheaMTWatkinsJTNational Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatmentsArch Gen Psychiatry198946119719822684085
   PubMed Web of Science ®Google Scholar
• KhanALeventhalRMKhanSRBrownWASeverity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration databaseJ Clin Psychopharmacol2002221404511799341
   PubMed Web of Science ®Google Scholar
• KhanABrodheadAEKoltsRLBrownWASeverity of depressive symptoms and response to antidepressants and placebo in antidepressant trialsJ Psychiatr Res200539214515015589562
   PubMed Web of Science ®Google Scholar
• FournierJCDeRubeisRJHollonSDAntidepressant drug effects and depression severity: a patient-level meta-analysisJAMA20103031475320051569
   PubMed Web of Science ®Google Scholar
• RutherfordBRRooseSPA model of placebo response in antidepressant clinical trialsAm J Psychiatry2013170772373323318413
   PubMed Web of Science ®Google Scholar
• ManciniMWadeAGPerugiGLenox-SmithASchachtAImpact of patient selection and study characteristics on signal detection in placebo-controlled trials with antidepressantsJ Psychiatr Res201451212924462042
   PubMed Web of Science ®Google Scholar
• PosternakMAZimmermanMKeitnerGIMillerIWA reevaluation of the exclusion criteria used in antidepressant efficacy trialsAm J Psychiatry2002592191200
   Web of Science ®Google Scholar
• CohenDConsoliABodeauNPredictors of placebo response in randomized controlled trials of psychotropic drugs for children and adolescents with internalizing disordersJ Child Adolesc Psychopharmacol2010201394720166795
   PubMed Web of Science ®Google Scholar
• BialikRJRavindranAVBakishDLapierreYDA comparison of placebo responders and nonresponders in subgroups of depressive disorderJ Psychiatry Neurosci19952042652707647079
   PubMed Web of Science ®Google Scholar
• WalshBTSeidmanSNSyskoRGouldMPlacebo response in studies of major depression: variable, substantial, and growingJAMA2002287141840184711939870
   PubMed Web of Science ®Google Scholar
• SinyorMLevittAJCheungAHDoes inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analysesJ Clin Psychiatry201071327027920122371
   PubMed Web of Science ®Google Scholar
• BridgeJABirmaherBIyengarSBarbeRPBrentDAPlacebo response in randomized controlled trials of antidepressants for pediatric major depressive disorderAm J Psychiatry20091661424919047322
   PubMed Web of Science ®Google Scholar
• PosternakMAZimmermanMTherapeutic effect of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials: meta-analysisBr J Psychiatry200719028729217401033
   PubMed Web of Science ®Google Scholar
• DunlopBWThaseMEWunCCA meta-analysis of factors impacting detection of antidepressant efficacy in clinical trials: the importance of academic sitesNeuropsychopharmacology201237132830283622910458
   PubMed Web of Science ®Google Scholar
• RutherfordBRCooperTMPersaudALess is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropoutJ Clin Psychiatry201374770371523945448
   PubMedGoogle Scholar
• KobakKALeuchterADeBrotaDSite versus centralized raters in a clinical depression trial: impact on patient selection and placebo responseJ Clin Psychopharmacol201030219319720520295
   PubMed Web of Science ®Google Scholar